Uncategorized

If you want profit then buy this pharma stock, HDFC Securities advised

Multibagger Stock Tips: Pharmaceutical company Indoco Remedies is one of the top stocks by domestic brokerage and research firm HDFC Securities with a two-quarter timing. Indoco Remedies has presence in the domestic market, US and EU markets and emerging markets. The company is a brand in the domestic formulation business in the acute, chronic/sub-chronic segment.

The brokerage said that the pharma firm expects strong growth in India business, led by opportunities arising out of the Kovid portfolio and new launches in FY22. The company offers therapeutics in areas such as stomatology, respiratory, ophthalmology, gastro-intestinal, vitamins, women’s health and anti-infection drugs.

HDFC Securities has given a buy advice on the stock of this company. HDFC Securities said, “We think investors can buy the stock in the 457-462 band and add more dips at the 413-419 band for a base case target of ₹506 and a bull case target price of ₹540 in the next two quarters.” can.”

Indoco Remedies Ltd., is a fully integrated, research-oriented pharma company engaged in manufacturing and marketing of Formulations (Finished Dose Forms) and Active Pharmaceutical Ingredients (APIs).

Disclaimer: (The information provided here is for informational purposes only. It is important to mention here that investing in the market is subject to market risks. Always consult an expert before investing money as an investor. Anyone from ABPLive.com Also investing money is never advised here.)

Read also:

Multibagger Stock Tips: This stock has doubled investors’ money in 2021, gave great returns

Multibagger Stock Tips: These 3 stocks proved to be multibagger stocks this year, made investors rich

.

Shivam Bangwal

Shivam Bangwal is an Indian based entrepreneur who is a tech, travel and coding enthusiast with a post graduation degree on Master's of Computer Applications. He is a founder of Youthistaan, People News Chronicle, Hitchhike TV, Branding Panther and many more.

Leave a Reply

Your email address will not be published.

Back to top button